Hello, Fool! | Login | Signup | My Fool
Oct 15, 2008 10:26 PM ET | Feedback | Site Changes | Help
The Company along with its subsidiaries is an owner and operator of ambulatory surgery centers.
View Ticker Page (NOVA)
Results 1 - 10 of 16 : 12
Recs
JJRzut (97.58) Submitted: 6/27/07 2:40 PM : Start Price: $6.04 NOVA Score: 12.46
Started watching this one about two months ago and it is down 15% so I decided to revisit and it passed the mustard. For background the company's main operating strategy is to acquire, develop, and operate ambulatory surgery...
Report this Post Replies: 0 | Reply
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
pomskua (40.75) Submitted: 2/08/07 12:42 AM : Start Price: $7.29 NOVA Score: -2.09
This stock will take a few years to mature. Managment team is solid and visionary - a nice combination for those willing to wait through the costs of acquisitions. ASCs are gaining in popularity, especially with outpatient procedures.
KatWoman50 (23.33) Submitted: 1/25/07 12:57 PM : Start Price: $7.57 NOVA Score: -5.04
Ambulatory surgery is the future as hospital rooms get more expensive and technology improves with less invasive surgical techniques.
NWTOGME (< 20) Submitted: 10/07/08 3:08 AM : Start Price: $4.06 NOVA Score: 23.60
Nice L/R Hit this one hard tommorrow.
quad80 (60.92) Submitted: 10/02/08 4:17 PM : Start Price: $4.29 NOVA Score: 22.55
growth looks promising
bluegreene (79.49) Submitted: 9/21/07 1:23 PM : Start Price: $4.64 NOVA Score: 35.45
GOOD MORNINGSTAR REPORT
jordangrant (47.60) Submitted: 8/03/07 5:24 AM : Start Price: $5.33 NOVA Score: 21.05
Top line is growing very strongly. Bottom line will take a while to catch up, due to the fact they are borrowing to finance acquisitions. Management shows a very long-term view and is in a strong growth industry. When the bottom line catches up with ...
eXigy (99.52) Submitted: 7/10/07 3:46 AM : Start Price: $6.10 NOVA Score: 12.69
Estimated to fire-up revenue by 3.5 times by the end of the year.ASCs are sort of specified medical segment niche, so the company would probably climb up. It's also not that far from 52W low - another reason to expect growth.
buylowrk (50.97) Submitted: 7/17/07 10:09 AM : Start Price: $6.17 NOVA Score: 12.21
Added to my positions yesterday. Just could not pass up the great prices. With the Kalamazoo center and the interest savings I think the earnings in Q3 are going to make anyone happy they bought at the current prices.
toroandbruin (49.64) Submitted: 9/19/06 7:36 PM : Start Price: $8.40 NOVA Score: -16.36
It is an undervalued microcap which should go up in January along with other good microcaps.